Health · 1 views
Researchers propose new target, repurposed drugs to make CAR T-cell therapy safer
This article has been reviewed according to Science X's editorial process and policies .
Story Brief
This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility: Add as preferred source Selection criteria for mitochondrial-targeted drug repurposing candidates for ICANS management in CAR T-cell therapy. Credit: Frontiers in Pharmacology (2026).
Read full article on Medical XpressAI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedCoverage Context
More from Health
Continue reading recent Health coverage
- Striking hospital employees sound alarm over workplace violenceContinue reading
- Leading hemp-derived cannabinoid brands lean on lifestyle and youth appeals on social mediaContinue reading
- Medicare’s Paying Less for Cataract Surgery. Eye Doctors Are Turning to Lucrative Lasers.Continue reading
- She grew up unvaccinated. Now she’s a leading voice for science — and empathyContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow